H.C. Wainwright has recently initiated Verve Therapeutics Inc (VERV) stock to Buy rating, as announced on April 8, 2024, according to Finviz. Earlier, on April 13, 2023, Canaccord Genuity had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback